Drs El-Khoueiry and Hughes-Halbert on the Importance of a Multidisciplinary Approach in Cancer Care
March 17th 2023Anthony B. El-Khoueiry, MD, and Chanita Hughes-Halbert, PhD, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.
Read More
HCC: Applying Recent Data Into Practice
Read More
HCC: Emerging Therapies Under Investigation
Read More
Combination Regimens for HCC Treatment
Read More
Emerging Biomarkers in Hepatocellular Carcinoma
Read More
HCC: Liver Function and Treatment Decisions
Read More
Safety Profiles of Novel Therapies for HCC
Read More
Sequencing of Novel Therapies in HCC
Read More
Regorafenib or Cabozantinib for Second-Line HCC
Read More
Selecting Second-Line Therapy for HCC
Read More
Second-Line Treatment for Hepatocellular Carcinoma
Read More
Novel Combinations to Treat HCC
Read More
Read More
HCC: Treating Patients With Atezolizumab/Bevacizumab
Read More
IO and VEGF Inhibition in Hepatocellular Carcinoma
Read More
Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma
Read More
Locoregional and Systemic Therapy for HCC
Read More
Hepatocellular Carcinoma: Diagnostic Work-Up
Read More
Surveillance for Hepatocellular Carcinoma
Read More
Incidence of Liver Cancer in the US
Read More